BioSpace News Archive

InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN) (OTCQX: IMLFF), a clinical stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannabinol (CBN), will report financial

Heat Biologics, Inc. today announced it has been issued a patent (US Patent No. 10,758,611)

Establishment Labs Holdings Inc., a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announced that CEO and Founder Juan José Chacón-Quirós and Chief Financial Officer Renee Gaeta will participate in the 2020 Wells Fargo Virtual Healthcare Conference, which is being held September 9-10, 2020.

The U.S. Food and Drug Administration has awarded Rare Pediatric Disease Designation (RPDD) for diffuse intrinsic pontine glioma (DIPG) and Orphan Drug Designation for treatment of malignant glioma to OKN-007, an investigational drug discovered at the Oklahoma Medical Research Foundation and being developed by Oblato, Inc.

Tottenham Acquisition I Limited (“Tottenham”) (NASDAQ: TOTA TOTAU, TOTAW, TOTAR), a special purpose acquisition company, today announced that it has entered into a definitive merger agreement (the “Merger Agreement”) for a business combination with Clene Nanomedicine, Inc. (“Clene”),

Through a new multi-year agreement, Humana will capitalize on infrastructure and capabilities offered by Salesforce Health Cloud to create an integrated health experience for its members

The COVID-19 testing program will test principals, teachers and staff in preparation for a safer back-to-school environment

MetricStream, the independent market leader in enterprise cloud applications for Governance, Risk, and Compliance (GRC)/Integrated Risk Management, today announced that the company has been positioned as a Leader in the 2020 Gartner Magic Quadrant for IT Vendor Risk Management Tools.

CATO SMS unveiled its new brand , revealing an updated look and logo capturing the company’s powerful offering following the merger of CATO Research, LLC and Specialized Medical Services-oncology BV.

Humanigen, Inc., (HGEN) (“Humanigen”), announced today that Cameron Durrant, MD, MBA, Chief Executive Officer, Dale Chappell, MD, MBA, Chief Scientific Officer, and Timothy Morris, Chief Operating and Financial Officer of Humanigen will present company overviews and business updates at the following upcoming investor conferences: LD Micro 500 Conference at 2:20 p.m. on Thursday, September 3, 2020 Bair